You work in device regulatory, clinical, or competitive intelligence. ClinicaLister pulls a device's full FDA picture — clearance, classification, GUDID identity, recalls, adverse events, and safety signals — onto one screen, cross-filters it with charts, and maps each device to the trials that reference it, so the five-lookup scavenger hunt is already done.
The highest-leverage things ClinicaLister does for a device / medtech professional.
Every recurring activity, mapped to what ClinicaLister does — on which surface (the App, the MCP graph, or both), the time it saves, and how confident that claim is.
| Activity | What ClinicaLister does | Surface | Time saved | Confidence |
|---|---|---|---|---|
| Device competitive landscape by product code / advisory committee | Filter and roll up the full device table into a cross-filtering landscape by class, submission type, and advisory committee — every 510(k)/PMA cross-reference in one view. | Both | manual 510(k)/PMA cross-refs → one cross-filtering landscape | High |
| 510(k) predicate selection & chain analysis | Surfaces predicate-device data and a chain analysis that flags the most-cited predicates and any chain contaminated by a later recall. | Both | predicate shortlist with contamination flag | Medium |
| Recall pattern & risk monitoring | Recall history and a recall-trend chart show exposure by class, firm, and reason over time. | Both | recall exposure by class/firm/reason + over-time trend | High |
| MAUDE post-market surveillance / AE trending | Adverse-event reports at three levels — this device, same manufacturer, and product code — tagged by malfunction, injury, and death and trended over time. | Both | AE trend without querying openFDA by hand | High |
| Safety-signal detection | Genuine disproportionality scoring at the product-code level surfaces adverse-event clusters as candidate signals. | Both | disproportionate AE clustering surfaced as candidates | Medium |
| GUDID product lookup (MRI, sterilization, latex, combination) | One panel of GUDID attributes — MRI safety, sterilization, latex, single-use, prescription status, and combination/kit flags — instead of a lookup per device identifier. | Both | instant attribute lookup vs AccessGUDID per DI | High |
| Device-trial evidence mapping / Class III gaps | Confidence-scored device-to-trial links show which devices have clinical evidence and which lack it. | Both | which devices have trial evidence and which lack it | High |
| Regulatory pathway / classification profile | The full classification profile — class, implant and life-sustaining flags, regulation number, decision code and date, and expedited-review status — sits beside the device. | Both | full regulatory profile beside the device | High |
| Establishment / registration intelligence | Registered establishments by product code, with firm name and location, read as a manufacturing-footprint and competitor-presence signal. | Both | manufacturing-footprint / competitor-presence signal | Medium |
| Combination-product screening | Identifies combination products and lists their constituent components. | MCP | identifies combination devices and their parts | Medium |
| Competitor device tracking (new clearances / supplements) | Filter by applicant, trade name, and decision date, then auto-follow a firm or product code to watch clearance activity without re-running searches. | Both | watches clearance activity without weekly re-runs | Medium |
| Run a full sourced device report via agent | Your AI assistant assembles a decision-ready, source-attributed device intelligence report on request. | MCP | decision-ready, source-attributed report | High |
Straight answers on where ClinicaLister stops today — so there are no surprises.
US-FDA and GUDID-centric. Device coverage is built on US FDA and GUDID data — there's no EU MDR / EUDAMED, CE-mark, or notified-body depth.
Public FDA data only. No internal complaint database, CAPA / QMS / eQMS, or design-history-file content — this is decision support, not a quality system.
Recall and designation data can lag. A clean recall result for one product code isn't proof a device is recall-free, and the expedited-review flag can miss a live breakthrough designation — cross-check the specific device against FDA's recall and breakthrough lists before a go/no-go decision.
Adverse-event surveillance carries reporting bias. Counts reflect voluntary and mandatory reports with under- and over-reporting, and disproportionality scores flag candidates, not confirmed causal findings.
Not a submission or quality system. No 510(k)/PMA authoring, eSTAR, or GUDID data entry, and no system of record for filings — and device-to-trial links are confidence-scored suggestions, not asserted facts.
The whole FDA device dossier on one screen — 510(k)/PMA clearance, classification, GUDID identity, recalls, adverse-event signals, and registrations — with predicate-and-recall analysis and confidence-scored links from each device to the trials that cite it.